Research Ethics 16 (3-4):1-8 (2020)

Authors
Abstract
There is too much that we do not know about COVID-19. The longer we take to find it out, the more lives will be lost. In this paper, we will defend a principle of risk parity: if it is permissible to expose some members of society (e.g. health workers or the economically vulnerable) to a certain level of ex ante risk in order to minimize overall harm from the virus, then it is permissible to expose fully informed volunteers to a comparable level of risk in the context of promising research into the virus. We apply this principle to three examples of risky research: skipping animal trials for promising treatments, human challenge trials to speed up vaccine development, and low-dose controlled infection or “variolation.” We conclude that if volunteers, fully informed about the risks, are willing to help fight the pandemic by aiding promising research, there are strong moral reasons to gratefully accept their help. To refuse it would implicitly subject others to still graver risks.
Keywords research ethics  clinical trials  COVID-19  human challenge trials  variolation
Categories (categorize this paper)
ISBN(s)
DOI 10.1177/1747016120931920
Options
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy

 PhilArchive page | Other versions
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library

References found in this work BETA

Limits to Research Risks.F. G. Miller & S. Joffe - 2009 - Journal of Medical Ethics 35 (7):445-449.
Ebola Vaccine Trials.Godfrey B. Tangwa, Katharine Browne & Doris Schroeder - 2018 - In Doris Schroeder, Julie Cook, François Hirsch, Solveig Fenet & Vasantha Muthuswamy (eds.), Ethics Dumping: Case Studies From North-South Research Collaborations. Springer. pp. 49-60.

Add more references

Citations of this work BETA

Pandemic Ethics and Status Quo Risk.Richard Yetter Chappell - 2022 - Public Health Ethics 15 (1):64-73.

View all 12 citations / Add more citations

Similar books and articles

Ethical Considerations for Epidemic Vaccine Trials.Joshua Teperowski Monrad - 2020 - Journal of Medical Ethics 46 (7):465-469.
Ethics Status of Clinical Research and Trials in Developing Countries.Yuanyuan Liu - 2015 - Eubios Journal of Asian and International Bioethics 25 (4):124-127.
Informed Consent in Emergency Research: A Contradiction in Terms.Malcolm G. Booth - 2007 - Science and Engineering Ethics 13 (3):351-359.

Analytics

Added to PP index
2020-05-30

Total views
510 ( #17,877 of 2,520,899 )

Recent downloads (6 months)
49 ( #17,084 of 2,520,899 )

How can I increase my downloads?

Downloads

My notes